Molecular Profiling In Nsclc: A Pilot Study To Screen For New Therapeutic Targets

JOURNAL OF CLINICAL ONCOLOGY(2014)

引用 0|浏览8
暂无评分
摘要
e22158 Background: NSCLC is a broad category of lung cancer with multiple subsets of molecular abnormalities. EGFR mutation positive patients constitute 30-50% of NSCLC, and hence they derive the b...
更多
查看译文
关键词
molecular profiling,nsclc,new therapeutic targets
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要